Jörg‐Christian Tonn

Author

Jörg‐Christian Tonn

Also Known As

Jörg C. Tonn, JJrg-Christian Tonn, Jorg-Christian Tonn, JÖRg‐Christian Tonn, Jörg-Christian Tonn, Jörg‐Christian Tonn, Sabine Streitwieser, Tonn, JÃ¶rg-Christian, Tonn, Jörg-Christian

238

Publications

9.4K

Citations

H-Index

100

Concepts

All Affiliations

Ludwig-Maximilians-Universität München LMU Klinikum German Cancer Research Center Heidelberg University Deutschen Konsortium für Translationale Krebsforschung

About

Jörg‐Christian Tonn is an author at Ludwig-Maximilians-Universität München specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	49	3.3K
2	Health Sciences	21	25	2.2K
3	Engineering	3	3	102
4	Anatomy	1	1	12
5	Biochemistry	1	1	45

Jörg‐Christian Tonn

114

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME Walter Stummer, H. J. Reulen, Thomas R. Meinel, Neurosurgery	2008	1K
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, The Lancet Hematological MalignancyNeuro-oncologyTreatment StrategiesMedicineStandard Temozolomide Therapy	2019	556
Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study Walter Stummer, Jörg‐Christian Tonn, H. Maximilian Mehdorn, Journal of neurosurgery	2010	290
Positron Emission Tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus Magnetic Resonance Imaging in the Diagnosis of Recurrent Gliomas Walter Rachinger, Claudia Goetz, Gabriele Pöpperl, Neurosurgery	2005	286
5-Aminolevulinic Acid-derived Tumor Fluorescence Walter Stummer, Jörg‐Christian Tonn, Claudia Goetz, Neurosurgery	2013	271
Increased <sup>68</sup>Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue Walter Rachinger, Veit M. Stoecklein, Nicole A. Terpolilli, Journal of Nuclear Medicine	2015	199
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Nathalie Jansen, Vera Graute, Lena Armbruster, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyMri-suspected Low-grade GliomaMedical ImagingPet-mriNeuroimaging	2012	181
Expression of Integrin α<sub>v</sub>β<sub>3</sub> in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature Oliver Schnell, Bjarne Krebs, Erika Wagner, Brain Pathology PathologyHigh-grade GliomasGliomaTumor BiologyNeuro-oncology	2008	170
Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Jörg‐Christian Tonn, Walter Stummer PubMed Neuro-oncologySurgical OncologyOncologic ImagingGlioma5-Aminolevulinic Acid	2008	160
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas E. M. Grasbon-Frodl, Friedrich W. Kreth, Michael Ruiter, International Journal of Cancer	2007	152

Page 1